SCHEMBL19181585

SCHEMBL19181585

NCCCNCCN(CCCN)CCNCCCN

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.57
CA6 P23280 4/20 0.57
CA7 P43166 4/20 0.57
CA9 Q16790 4/20 0.57
CA14 Q9ULX7 4/20 0.57
CA5B Q9Y2D0 4/20 0.57
CA2 P00918 3/20 0.57
CA4 P22748 3/20 0.57
CA5A P35218 3/20 0.57
ALOX15 P16050 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
CASP2 P42575 2/20 0.57
F13A1 P00488 2/20 0.57
CYP1A2 P05177 2/20 0.57
THPO P40225 2/20 0.57
CYP2C19 P33261 2/20 0.57
RECQL P46063 2/20 0.57
HSD17B10 Q99714 1/20 0.57
CYP2C9 P11712 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL831497 1.00 CA12 (0.57) CA12CA6CA7CA9CA14
SCHEMBL19179134 0.98 TDP1 (0.58) CA12CA6CA7CA9CA14
SCHEMBL19179346 0.98 CASP2 (0.62) CA12CA6CA7CA9CA14
SCHEMBL5145932 0.95 CA12 (0.52) CA12CA6CA7CA9CA14
SCHEMBL19179347 0.95 CASP2 (0.59) CA12CA6CA7CA9CA14
SCHEMBL19179129 0.95 CYP2C19 (0.50) CA12CA6CA7CA9CA14
SCHEMBL8766714 0.92 CYP2C19 (0.54) CA12CA6CA7CA9CA14
SCHEMBL832891 0.92 TDP1 (0.62) CA12CA6CA7CA9CA14
SCHEMBL4143342 0.90 CA12 (0.57) CA12CA6CA7CA9CA14
SCHEMBL13336449 0.90 CA12 (0.65) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899985-B2 Amine alkenyl substituted succinimide reaction product fuel additives, compositions, and methods EVONIK OPERATIONS GMBH (DE) 2021-01-26 US claimed
US-10899986-B2 Substituted Mannich base fuel additives, compositions, and methods EVONIK OPERATIONS GMBH (DE) 2021-01-26 US claimed
US-10676564-B2 Amidoamine and polyamide curing agents, compositions, and methods EVONIK OPERATIONS GMBH (DE) 2020-06-09 US claimed
EP-3504303-B1 SUBSTITUTED MANNICH BASE FUEL ADDITIVES, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2020-04-01 EP claimed
EP-3411421-B1 AMIDOAMINE AND POLYAMIDE CURING AGENTS, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2019-12-25 EP claimed
EP-3504303-A1 SUBSTITUTED MANNICH BASE FUEL ADDITIVES, COMPOSITIONS, AND METHODS Evonik Degussa GmbH (DE) 2019-07-03 EP claimed
EP-3504304-A1 AMINE ALKENYL SUBSTITUTED SUCCINIMIDE REACTION PRODUCT FUEL ADDITIVES, COMPOSITIONS, AND METHODS Evonik Degussa GmbH (DE) 2019-07-03 EP claimed
US-20190169515-A1 SUBSTITUTED MANNICH BASE FUEL ADDITIVES, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2019-06-06 US claimed
US-20190169514-A1 AMINE ALKENYL SUBSTITUTED SUCCINIMIDE REACTION PRODUCT FUEL ADDITIVES, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2019-06-06 US claimed
EP-3411421-A1 AMIDOAMINE AND POLYAMIDE CURING AGENTS, COMPOSITIONS, AND METHODS Evonik Degussa GmbH (DE) 2018-12-12 EP claimed
WO-2018039563-A1 SUBSTITUTED MANNICH BASE FUEL ADDITIVES, COMPOSITIONS, AND METHODS EVONIK DEGUSSA GMBH (DE) 2018-03-01 WO claimed
WO-2018039571-A1 AMINE ALKENYL SUBSTITUTED SUCCINIMIDE REACTION PRODUCT FUEL ADDITIVES, COMPOSITIONS, AND METHODS EVONIK DEGUSSA GMBH (DE) 2018-03-01 WO claimed
WO-2017136333-A1 AMIDOAMINE AND POLYAMIDE CURING AGENTS, COMPOSITIONS, AND METHODS EVONIK DEGUSSA GMBH (DE) 2017-08-10 WO claimed
US-20170218115-A1 AMIDOAMINE AND POLYAMIDE CURING AGENTS, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2017-08-03 US claimed
US-20250223449-A1 COATINGS JOTUN A/S (NO) 2025-07-10 US disclosed
US-20250163293-A1 COATING COMPOSITION JOTUN A/S (NO) 2025-05-22 US disclosed
WO-2025051850-A1 ANTIFOULING COATING SYSTEM JOTUN A/S (NO) 2025-03-13 WO disclosed
US-20170240691-A1 BENZYLATED MANNICH BASE CURING AGENTS, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2017-08-24 US disclosed
WO-2017136333-A1 AMIDOAMINE AND POLYAMIDE CURING AGENTS, COMPOSITIONS, AND METHODS EVONIK DEGUSSA GMBH (DE) 2017-08-10 WO disclosed
US-20170218115-A1 AMIDOAMINE AND POLYAMIDE CURING AGENTS, COMPOSITIONS, AND METHODS EVONIK OPERATIONS GMBH (DE) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10899986-B2 Substituted Mannich base fuel additives, compositions, and methods H1-2, H1-0, H1-3 CA12 550/4885CA6 2936/4885CA7 2124/4885
US-10676564-B2 Amidoamine and polyamide curing agents, compositions, and methods NAAA, FAAH2, H1-2 CA12 2527/4885CA6 3163/4885CA7 2744/4885
US-20170240691-A1 BENZYLATED MANNICH BASE CURING AGENTS, COMPOSITIONS, AND METHODS H1-0, SRM, H1-2 CA12 2279/4885CA6 4127/4885CA7 2504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.